Advances in the Use of Lipids for Drug Delivery Systems
American Journal of Pharmaceutics · 2022-02-28 · 3 (1) · 32-42
DOI: 10.71465/ajph2164 ↗At a glance
Journal article in American Journal of Pharmaceutics, published online on 2022-02-28. Written by Dr. John Smith. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Lipids have gained significant attention in drug delivery systems due to their biocompatibility, ease of functionalization, and ability to encapsulate a wide range of therapeutic agents. Lipid-based carriers such as liposomes, lipid nanoparticles (LNPs), and solid lipid nanoparticles (SLNs) have revolutionized the pharmaceutical industry by offering controlled release, targeted delivery, and enhanced bioavailability. This article explores the advancements in lipid-based drug delivery systems, their mechanisms, applications, and challenges in clinical settings. Current innovations in lipid formulations and their role in personalized medicine are also discussed. These systems hold potential for improving the treatment of various diseases, particularly cancer, viral infections, and neurological disorders.
Cite
APA
Smith, D. J. (2022). Advances in the Use of Lipids for Drug Delivery Systems. American Journal of Pharmaceutics, 3(1), 32-42. https://doi.org/10.71465/ajph2164
Vancouver
Smith DJ. Advances in the Use of Lipids for Drug Delivery Systems. American Journal of Pharmaceutics. 2022;3(1):32-42. doi:10.71465/ajph2164
BibTeX
@article{Smith2022,
author = {Smith, Dr. John},
title = {Advances in the Use of Lipids for Drug Delivery Systems},
journal = {American Journal of Pharmaceutics},
year = {2022},
volume = {3},
number = {1},
pages = {32--42},
doi = {10.71465/ajph2164}
}
EUVIMED